Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline

Brain metastases are common among adult patients with solid malignancies and are increasingly being treated with stereotactic radiosurgery (SRS). As more patients with brain metastases are becoming eligible for SRS, there is a need for practical review of patient selection and treatment consideratio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in radiation oncology 2024-03, Vol.9 (3), p.101402, Article 101402
Hauptverfasser: Ladbury, Colton, Pennock, Michael, Yilmaz, Tugba, Ankrah, Nii-Kwanchie, Andraos, Therese, Gogineni, Emile, Kim, Grace Gwe-Ya, Gibbs, Iris, Shih, Helen A., Hattangadi-Gluth, Jona, Chao, Samuel T., Pannullo, Susan C., Slotman, Ben, Redmond, Kristin J., Lo, Simon S., Schulder, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Brain metastases are common among adult patients with solid malignancies and are increasingly being treated with stereotactic radiosurgery (SRS). As more patients with brain metastases are becoming eligible for SRS, there is a need for practical review of patient selection and treatment considerations. Two patient cases were identified to use as the foundation for a discussion of a wide and representative range of management principles: (A) SRS alone for 5 to 15 lesions and (B) a large single metastasis to be treated with pre- or postoperative SRS. Patient selection, fractionation, prescription dose, treatment technique, and dose constraints are discussed. Literature relevant to these cases is summarized to provide a framework for treatment of similar patients. Treatment of brain metastases with SRS requires many considerations including optimal patient selection, fractionation selection, and plan optimization. Case-based practice guidelines developed by the Radiosurgery Society provide a practical guide to the common scenarios noted above affecting patients with metastatic brain tumors.
ISSN:2452-1094
2452-1094
DOI:10.1016/j.adro.2023.101402